Trial Outcomes & Findings for Thromboelastography-derived Functional Fibrinogen Levels (NCT NCT01992757)
NCT ID: NCT01992757
Last Updated: 2018-10-03
Results Overview
FLEV values obtained during rewarming while on cardiopulmonary bypass (CPB) were compared to FLEV values obtained immediately after CPB and protamine administration. For all patients included, the mean values for rewarming FLEV and mean values for post-CPB FLEV were obtained. If the mean difference for the two timepoints was not statistically different by t-test, then the primary outcome would demonstrate the value of obtaining a rewarming FLEV sample.
COMPLETED
51 participants
Change in FLEV from rewarming and after cardiopulmonary bypass
2018-10-03
Participant Flow
Participant milestones
| Measure |
Cardiac Surgery With Cardiopulmary Bypass
Patients over the age of 18 years undergoing cardiac surgery requiring CPB. Patients were excluded based on their need for emergency surgery, re-operative cardiac surgery, a history of coagulation disorders, and inability to sign consent.
|
|---|---|
|
Overall Study
STARTED
|
51
|
|
Overall Study
COMPLETED
|
49
|
|
Overall Study
NOT COMPLETED
|
2
|
Reasons for withdrawal
| Measure |
Cardiac Surgery With Cardiopulmary Bypass
Patients over the age of 18 years undergoing cardiac surgery requiring CPB. Patients were excluded based on their need for emergency surgery, re-operative cardiac surgery, a history of coagulation disorders, and inability to sign consent.
|
|---|---|
|
Overall Study
2 patients excluded due to FFP given.
|
2
|
Baseline Characteristics
Race and Ethnicity were not collected from any participant.
Baseline characteristics by cohort
| Measure |
Cardiac Surgery With Cardiopulmary Bypass
n=49 Participants
patients over the age of 18 years undergoing cardiac surgery requiring CPB. patients were excluded based on their need for emergency surgery, re-operative cardiac surgery, a history of coagulation disorders, and inability to sign consent.
|
|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=49 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
26 Participants
n=49 Participants
|
|
Age, Categorical
>=65 years
|
23 Participants
n=49 Participants
|
|
Age, Continuous
|
63.1 years
n=49 Participants
|
|
Sex: Female, Male
Female
|
20 Participants
n=49 Participants
|
|
Sex: Female, Male
Male
|
29 Participants
n=49 Participants
|
|
Region of Enrollment
United States
|
49 participants
n=49 Participants
|
PRIMARY outcome
Timeframe: Change in FLEV from rewarming and after cardiopulmonary bypassPopulation: 49 patients undergoing cardiac surgery with CPB.
FLEV values obtained during rewarming while on cardiopulmonary bypass (CPB) were compared to FLEV values obtained immediately after CPB and protamine administration. For all patients included, the mean values for rewarming FLEV and mean values for post-CPB FLEV were obtained. If the mean difference for the two timepoints was not statistically different by t-test, then the primary outcome would demonstrate the value of obtaining a rewarming FLEV sample.
Outcome measures
| Measure |
FLEV Difference During Rewarming & Post-cardiopulmonary Bypass
n=49 Participants
All enrolled patients were in a single arm with multiple timepoints. FLEV values were obtained at baseline, rewarming, and post-CPB. The primary outcome was to compare the rewarming and post-CPB values to determine if a significant difference exists.
|
|---|---|
|
Change in Thromboelastography-derived Functional Fibrinogen Level (FLEV)
|
-1.1 mg/dL
Interval -25.8 to 23.6
|
SECONDARY outcome
Timeframe: Clauss vs FLEV for rewarming and post-CPBPopulation: 49 patients undergoing cardiac surgery with CPB. The measure is the difference of the FLEV and the Clauss assay (i.e. FLEV minus Clauss since the FLEV is consistently higher).
This secondary outcome aimed to determine if standard laboratory assays for fibrinogen (Clauss) provided values similar to TEG-based functional fibrinogen (FLEV). The difference between the means at various timepoints is calculated in mg/dL.
Outcome measures
| Measure |
FLEV Difference During Rewarming & Post-cardiopulmonary Bypass
n=49 Participants
All enrolled patients were in a single arm with multiple timepoints. FLEV values were obtained at baseline, rewarming, and post-CPB. The primary outcome was to compare the rewarming and post-CPB values to determine if a significant difference exists.
|
|---|---|
|
Difference in Clauss Assay and FLEV
Mean Clauss vs FLEV difference at rewarming
|
120.6 mg/dL
Interval 104.1 to 137.1
|
|
Difference in Clauss Assay and FLEV
Mean Clauss vs FLEV difference post-CPB
|
119.5 mg/dL
Interval 101.7 to 137.4
|
Adverse Events
Cardiac Surgery With Cardiopulmary Bypass
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place